Literature DB >> 11750386

Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity.

F Diekmann1, J Waiser, L Fritsche, D Dragun, H H Neumayer, K Budde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11750386     DOI： 10.1016/s0041-1345(01)02375-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant.

Authors:  José M Álamo; Claudia Olivares; Lydia Barrera; Luis M Marín; Gonzalo Suarez; Carmen Bernal; Juan Serrano; Jordi Muntané; Francisco J Padillo; Miguel A Gómez
Journal:  World J Transplant       Date:  2015-03-24

Review 2.  Use of sirolimus in solid organ transplantation.

Authors:  Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis.

Authors:  Stefan Farkas; Matthias Hornung; Christine Sattler; Markus Guba; Markus Steinbauer; Matthias Anthuber; Hans Herfarth; Hans J Schlitt; Edward K Geissler
Journal:  Int J Colorectal Dis       Date:  2005-10-14       Impact factor: 2.571

Review 4.  Benefit-risk assessment of sirolimus in renal transplantation.

Authors:  Dirk R J Kuypers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies.

Authors:  Andrew Scott Mathis; Gwen Egloff; Hoytin Lee Ghin
Journal:  World J Transplant       Date:  2014-06-24

Review 6.  Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipients.

Authors:  Eric Thervet; Frank Martinez; Christophe Legendre
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

7.  Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects.

Authors:  Daniel Abramowicz; Karine Hadaya; Marc Hazzan; Nilufer Broeders; Anh-Dung Hoang; Lidia Ghisdal; Christian Noel; Karl Martin Wissing
Journal:  Nephrol Dial Transplant       Date:  2008-06-20       Impact factor: 5.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.